EFFICACY OF RECOMBINANT EPIDERMAL GROWTH FACTOR IN THE HEALING PROCESS OF DIABETIC ULCER
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2016, Vol 5, Issue 31
Abstract
OBJECTIVES To evaluate the efficacy of the Recombinant Epidermal Growth Factor in the healing of diabetic ulcer. To assess the tolerability of the Recombinant Epidermal Growth Factor in the diabetic ulcer management. METHODS Study Design: Randomized, interventional, prospective, comparative study. Study Centre: Department of General Surgery and Department of Diabetology, Thanjavur Medical College Hospital, Thanjavur. Study Period: February 2014-August 2015. Duration of Study: 18 Months. Sample Size: 60 (30+30), Study group A-30, Study group B-30. Sample Drug: Recombinant Epidermal Growth Factor. Selection Criteria. Inclusion Criteria 1. Age - 20-70 years. 2. Both sexes. 3. Fasting blood sugar <130 mgs/dL and postprandial blood sugar >130 mgs/dL <180 mgs/dL with treatment. 4. Patients with Grade 2 diabetic ulcer. 5. Patients with diabetes along with comorbidities like hypertension with BP <140/90 mmHg with antihypertensives, anaemia with haemoglobin between 8-10 gms%, chronic renal failure Stage 1 and 2, CAHD patients on drugs with no symptoms at present. 6. Palpable peripheral pulses or Doppler showing flow in peripheral vessels. 7. Patients who give consent and are willing for regular followup. Exclusion Criteria 1. Patients with extensive gangrenous changes. 2. Patients with vascular occlusion (Absent peripheral pulses or no flow in peripheral vessels in the Doppler study). 3. Patients with diabetic ketoacidosis or with fasting blood sugar >130 mgs/dL, postprandial blood sugar >180 mgs/dL in spite of treatment. 4. Patients with diabetes with hypertension with BP >140/90 mmHg, anaemia with haemoglobin <8 gms%, chronic renal failure with stage 3, 4, 5 congestive heart failure and recent onset myocardial infarction. 5. Pregnant or breastfeeding women. 6. Not willing for the study or not willing for regular visits. CONCLUSION The conclusion of this study is that Recombinant Epidermal Growth Factor is effective in the healing of diabetic ulcers at significantly higher rate. No adverse reactions are encountered. It is tolerated well by all the patients.
Authors and Affiliations
Antony , Rasool Raj
Keywords
Related Articles
- EP ID EP144099
- DOI 10.14260/jemds/2016/387
- Views 62
- Downloads 0
ANALYTICAL STUDY OF VIRAL FEVER CASES ADMITTED IN A TERTIARY CARE HOSPITAL, NELLORE, A.P
BACKGROUND Viral fevers are the cause for admission in the hospital during certain seasons of the year. Commonly, the hospitalisations often increase in the monsoon period during the months of July to November i...
INGUINAL HERNIA SURGERY UNDER LOCAL ANAESTHESIA, AS DAY CARE SURGERY AND COMPARISON AMONG THREE GROUP OF PATIENTS CLASSIFIED ACCORDING TO TYPE OF MESH USED
[b]BACKGROUND[/b]: Inguinal hernia repair is one of the most commonly performed operations worldwide. This study was done to evaluate, local anesthesia as choice of procedure for inguinal hernia as day care su...
A COMPARATIVE STUDY ON EFFECT OF LEMON JUICE WITH LEMON SEEDS VS. LEMON JUICE ALONE ON HIGH SENSITIVITY C-REACTIVE PROTEIN IN SUBJECTS WITH OBESITY UNDERGOING CALORIE RESTRICTION- A PILOT STUDY
BACKGROUND Obesity or overweight is the most common problem faced by millions of people in this world today. Obesity is a chronic inflammatory lifestyle related disorder that increases the preponderance for many illnesse...
NON-COMPACTION CARDIOMYOPATHY IN AN APPARENTLY HEALTHY PATIENT: A CASE REPORT
Non-compaction cardiomyopathy is a rare genetic cardiomyopathy caused by a disorder during endocardial morphogenesis and could be accompanied by life-threatening complications on presentation. The major clinic...
HISTOPATHOLOGICAL SPECTRUM OF HYSTERECTOMY SPECIMENS- A RETROSPECTIVE ANALYSIS AT IGIMS, PATNA, BIHAR
BACKGROUND Uterus is subjected to many benign and malignant diseases, which are managed by medical and surgical methods. In this study we analysed the spectrum of morphological changes noted in the hysterectomy specimen...